Suggestion to the founders of this: Explore insulin pump infusion sets and continuous glucose monitoring sensors as a possible market for your technology. This is a significant and growing market, and it's one where infection resistance is important: Non-professionals in non-sterile environments, inserting devices through the skin which stay there for between a few days and a couple weeks. Skin infections are one of the most common complications of both CSII and CGM systems.